Open-angle glaucoma
Conditions
Interventions
This is a prospective, randomized, two-arm clinical trial. Group 1: 30 patients with refractory glaucoma will receive surgical treatment Slow Coagulation (SC-CPC) Transscleral Diode Laser Cyclophotoco
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients between 18 and 80 years of age; Both genders; Uncontrolled intraocular pressure despite maximal topical therapy; Impossibility of performing trabeculectomy; Absence of previous cyclodestructive procedure
Exclusion criteria
Exclusion criteria: Single eyed patients; Albino phenotype; Previous ocular history of uveitis, surgery or corneal disease that precludes an intraocular pressure measurement; Presence of significant scleral thinning; Any medical conditions that prevent these individuals from providing reliable and valid data for the study; Patients enrolled in other prospective clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes of success will be absolute measure of intraocular pressure (IOP), with values between 6 and 21 mmHg; reduction of at least 30% from baseline value; absolute measure, with a value lower than the stipulated IOP target. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes evaluated will be the number of hypotensive medications, the number of complications occurring in the postoperative period and the need for re-treatment during the follow-up. | — |
Countries
Brazil
Contacts
Public ContactLuiz Beniz
Universidade Federal de São Paulo
Outcome results
None listed